Press Releases Zydus Lifesciences Limited

Stocks

ZYDUSLIFE

INE010B01027

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:49:31 11/06/2026 pm IST			5-day change	1st Jan Change
1,105.90 ^INR	+0.69%		+2.72%	+20.95%

10/06	Zydus Lifesciences Unit Secures Reduction in GST Tax Demands	MT
03/06	Zydus Lifesciences Receives USFDA Warning Letter for Baddi Facility	MT

Press Releases

27/05	Zydus Lifesciences : Mr. Kulin S. Lalbhai	PU
06/04	When Public Interest Tempers Interim Patent Relief: The Nivolumab Biosimilar Ruling	AQ
10/02	Zydus Lifesciences : Press Release 10-02-2026 NewspaperPublication10022026	PU
06/02	Essential Medicines & Injunctions – Delhi High Court's Landmark Balancing Act	AQ
14/01	Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO	AQ
07/01	The 'Wow' Factor: Section 11 And the Jurisprudence of Trademark Confusion in Food Brands	AQ
24/12	Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)	AQ
23/12	Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®	AQ
20/25/20	Zydus Lifesciences : Press Release 20-08-2025 Newspaperadvertisement20082025	PU
13/25/13	Delhi High Court Denies Roche Access To Zydus' Confidential Information	AQ
05/25/05	Quia Timet Action Succeeds In Patent Dispute Over Biosimilar Of Nivolumab	AQ
17/25/17	Zydus Lifesciences : Press Release 17-07-2025 NewspaperpublicationAGMnotice17072025	PU
09/25/09	Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes	BU
22/25/22	ITC Reversal Of Common ITC U/s17(2) Required In Relation To Activity Of Subscription And Redemption Of Mutual Funds	AQ
02/24/02	Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days	AQ
15/24/15	Zynext Ventures Invests in neuro42, A Company Developing Portable MRI Systems for Neuroimaging and Interventions	AQ
18/24/18	Zynext Ventures, the VC arm of Zydus Lifesciences, Announces Investment in Promaxo: Pioneering Point-of-Care Medical Imaging and Interventions with Next Generation MRI Systems	AQ
06/24/06	Sentynl Therapeutics Announces Global Acquisition of Zokinvy for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals	AQ
22/24/22	Zydus launches Mirabegron Extended-Release Tablets in the US	BU
29/23/29	PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines	AQ
28/22/28	Zydus Lifesciences : Loss of Share Certificates	PU
18/22/18	Tetanus Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space \| DelveInsight	AQ
07/22/07	Zydus Lifesciences : General updates	PU
13/22/13	Zydus Lifesciences : receives final approval from the USFDA for Lenalidomide Capsules 5 mg, 10 mg, 15 mg and 25 mg	PU
12/22/12	Zydus Lifesciences : receives final approval and 180 days shared exclusivity from the USFDA for Cariprazine Capsules	PU